Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

IVF breakthrough? new test spots healthy embryos in minutes!

NCT ID NCT05488236

Knowledge-focused Sponsor: Instituto Valenciano de Infertilidade de Lisboa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to pick the healthiest embryos for IVF. Instead of the usual expensive genetic test, researchers used a machine (NMR) to analyze the fluid embryos grow in. They looked for chemical differences between normal and abnormal embryos. The goal is to make embryo selection faster, cheaper, and less invasive, potentially helping more couples have a baby. 30 people took part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Apr 2021

Finished

Jun 2023

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy women who will undergo a In vitro fertilization followed by preimplantation genetic test for aneuploidy.

Ages

18 to 48 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: ≥18 and \<49 years old. * Body Mass Index ≥18.5 Kg/m2 and \<30 Kg/m2. * Planned for in vitro fertilization followed by preimplantation genetic test for aneuploidy. * Oocytes retrieval and fertilization by intracytoplasmic sperm injection * Six follicles over 14 mm on the day of the triggering. Gonadotropin-releasing hormone antagonist * Signed and dated informed consent. Exclusion Criteria: * Previous history of poor ovarian response (\<4 oocytes retrieved) with a maximal dose of ovarian stimulation (≥300 IU/day). * Presence of a medical condition which is known to affect assisted reproductive technologies outcome (e.g. thyroid dysfunction). * Active female smoking. * Current use of anti-depressants, anti-psychotics, steroids, antiepileptics or chemotherapy. * Those unable to comprehend the investigational nature of the proposed study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aneuploidy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

aneuploidy infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aneuploidy Infertility

Contacts and locations

Locations

  • Instituto Valenciano de Infertilidade

    Lisbon, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.